EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Copper(II) Cyclopeptides with High ROS-Mediated Cytotoxicity

Sonia Boga, David Bouzada, Roi Lopez-Blanco, Axel Sarmiento, Iria Salvadó, David Alvar Gil, José Brea iD, María Isabel Loza iD, Natalia Barreiro-Piñeiro iD, José Martínez-Costas iD, Silvia Mena, Gonzalo Guirado und 4 weitere

Bioconjugate Chemistry · 19.03.2025 · 36 (3) · 500-509

DOI: 10.1021/acs.bioconjchem.4c00561 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioconjugate Chemistry, online erschienen am 10.03.2025. Verfasst von Sonia Boga und 15 weiteren Autor:innen. Beteiligte Einrichtung: Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de …. Hauptthemen laut MEDLINE: Copper, Reactive Oxygen Species, Antineoplastic Agents, Peptides, Cyclic. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Estatal de Investigaci?n, Secretaria Xeral de Investigaci?n e Desenvolvemento, Xunta de Galicia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cu(II) coordination complexes are emerging as promising anticancer agents due to their ability to induce oxidative stress through reactive oxygen species (ROS) generation. In this study, we synthesized and characterized two novel Cu(II) metallopeptide systems, 1 /Cu(II) and 2 /Cu(II), derived from the oligocationic bipyridyl cyclopeptides 1 and 2, and designed to enhance the transport of Cu(II) into cells and increase ROS levels. Spectroscopic and electrochemical analyses confirmed the formation of stable metallopeptide species in aqueous media. Inductively coupled plasma mass spectrometry (ICP-MS) studies demonstrated that both metallopeptides significantly increase intracellular Cu(II) accumulation in NCI/ADR-RES cancer cells, highlighting their role as efficient Cu(II) transporters. Additionally, ROS generation assays revealed that 1 /Cu(II) induces a substantial increase in intracellular ROS levels, supporting the hypothesis of oxidative stress-induced cytotoxicity. Cell-viability assays further confirmed that both 1 /Cu(II) and 2 /Cu(II) exhibit strong anticancer activity in a number of cancer cell lines, with IC 50 values significantly lower than those of their free cyclopeptide counterparts or Cu(II) alone, showing an order of activity higher than that of cisplatin. Finally, molecular modeling studies provided further insights into the structural stability and coordination environment of Cu(II) within the metallopeptide complexes. These findings suggest that these Cu(II) cyclometallopeptide systems hold potential as novel metal-based therapeutic agents, leveraging Cu(II) transport and ROS increase as key strategies for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CopperReactive Oxygen SpeciesAntineoplastic AgentsPeptides, CyclicCoordination ComplexesHumansCell Line, TumorCell SurvivalOxidative Stress

Substanzen

CopperReactive Oxygen SpeciesAntineoplastic AgentsPeptides, CyclicCoordination Complexes

Autor:innen und Institutionen

  • Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Orgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
  • Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Química Inorgánica, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
  • Innopharma Drug Screening and Pharmacogenomics Platform. Center for Research in Molecular Medicine and Chronic Diseases (CiMUS). Department of Pharmacology, Pharmacy and Pharmaceutical Technology, Universidade de Santia…
  • Health Research Institute of Santiago de Compostela, 15782 Santiago de Compostela, Spain.
  • Centro Singular de Investigación en Química Biolóxica e Materiais Moleculares (CiQUS), Departamento de Bioquímica e Bioloxía Molecular, Universidade de Santiago de Compostela, 15782 Santiago de Compostela, Spain.
  • Departament de Química, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.

ORCID-Profile: José Brea, María Isabel Loza, Natalia Barreiro-Piñeiro, José Martínez-Costas, Peter Faller, M Eugenio Vázquez, Miguel Vázquez López

Förderung

  • Agencia Estatal de Investigaci?n
  • Secretaria Xeral de Investigaci?n e Desenvolvemento, Xunta de Galicia

Zitieren

APA

Boga, S., Bouzada, D., Lopez-Blanco, R., Sarmiento, A., Salvadó, I., Alvar Gil, D., Brea, J., Loza, M. I., Barreiro-Piñeiro, N., Martínez-Costas, J., Mena, S., Guirado, G., Santoro, A., Faller, P., Vázquez, M. E., & Vázquez López, M. (2025). Copper(II) Cyclopeptides with High ROS-Mediated Cytotoxicity. Bioconjugate Chemistry, 36(3), 500-509. https://doi.org/10.1021/acs.bioconjchem.4c00561

Vancouver

Boga S, Bouzada D, Lopez-Blanco R, Sarmiento A, Salvadó I, Alvar Gil D, et al. Copper(II) Cyclopeptides with High ROS-Mediated Cytotoxicity. Bioconjugate Chemistry. 2025;36(3):500-509. doi:10.1021/acs.bioconjchem.4c00561

BibTeX
@article{Boga2025,
  author = {Boga, Sonia and Bouzada, David and Lopez-Blanco, Roi and Sarmiento, Axel and Salvadó, Iria and Alvar Gil, David and Brea, José and Loza, María Isabel and Barreiro-Piñeiro, Natalia and Martínez-Costas, José and Mena, Silvia and Guirado, Gonzalo and Santoro, Alice and Faller, Peter and Vázquez, M Eugenio and Vázquez López, Miguel},
  title = {Copper(II) Cyclopeptides with High ROS-Mediated Cytotoxicity},
  journal = {Bioconjugate Chemistry},
  year = {2025},
  volume = {36},
  number = {3},
  pages = {500--509},
  doi = {10.1021/acs.bioconjchem.4c00561}
}
Kostenlos starten →